## Core Concept
Patent ductus arteriosus (PDA) is a congenital heart defect characterized by the persistent patency of the ductus arteriosus, a vascular structure that connects the pulmonary artery to the aortic isthmus during fetal development. Normally, the ductus arteriosus closes shortly after birth. The patency of this duct leads to abnormal blood flow between the aorta and pulmonary artery.

## Why the Correct Answer is Right
The correct answer relates to the fact that a patent ductus arteriosus results in a **left-to-right shunt**. This occurs because the pressure in the aorta is higher than in the pulmonary artery, causing oxygenated blood to flow from the aorta into the pulmonary artery. This shunting of blood increases pulmonary blood flow and can lead to pulmonary hypertension, heart failure, and increased workload on the heart over time.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, incorrect options regarding PDA might suggest a right-to-left shunt (which is more characteristic of PDA in the context of pulmonary hypertension) or might inaccurately describe the hemodynamic effects or clinical presentation.
- **Option B:** Similarly, without the specific content of Option B, it's challenging to provide a direct refutation. However, any option that inaccurately describes the pathophysiology, clinical presentation, or hemodynamic consequences of PDA would be incorrect.
- **Option C:** This option is also not provided but would be incorrect based on similar reasoning as Options A and B.

## Clinical Pearl / High-Yield Fact
A key clinical pearl regarding PDA is that **indomethacin**, a nonsteroidal anti-inflammatory drug (NSAID), is often used to promote closure of a patent ductus arteriosus in neonates. This is because NSAIDs inhibit prostaglandin synthesis, and prostaglandin E2 is known to maintain the patency of the ductus arteriosus.

## Correct Answer Line
**Correct Answer: D. [Correct statement about PDA]**